20031 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Ear
GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER EAR
#2GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER EAR
#3AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE VISUAL AND AUDITORY SYSTEMS
#4Formulation For Treatment of Middle Ear Infections Without Antibiotics
#5CHOLINERGIC GENE THERAPY TO PRESERVE HEARING
#6METHOD OF TREATING DISEASE
#7METHOD FOR THE TREATMENT OF AN AUDITORY DISEASE OR CONDITION
#8OTIC FORMULATIONS, METHODS AND DEVICES
#9LOCALIZED RELEASE OF SYSTEMICALLY CIRCULATING THERAPEUTIC SUBSTANCES
#10SLC26A4 REGULATORY ELEMENTS AND USES THEREOF
#11COMPOSITIONS AND METHODS FOR TREATING NON-AGE-ASSOCIATED HEARING IMPAIRMENT IN A HUMAN SUBJECT
#12HYPERTONIC PHARMACEUTICAL COMPOSITIONS CONTAINING AN ANTI-PLATINUM CHEMOPROTECTANT AGENT
#13GENE THERAPY SYSTEMS AND RELATED METHODS FOR TREATMENT OF HEARING LOSS
#14METHOD OF IDENTIFYING A BIOLOGICALLY-ACTIVE COMPOSITION FROM A BIOFILM
#15AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE VISUAL AND AUDITORY SYSTEMS
#16AAV-MEDIATED DELIVERY OF THERAPEUTIC ANTIBODIES TO THE INNER EAR
#17Topical Antifungal Non-Aqueous Formulations and Preparation Methods Thereof
#18TRANS-TYMPANIC MEMBRANE DELIVERY PLATFORM AND USES THEREOF
#19COMPOSITIONS AND METHODS FOR CONTROLLING CERUMEN PRODUCTION
#20Supraparticles
#21LIPID NANOPARTICLES FOR DELIVERY TO THE EYE OR EAR
#22ANTI-VEGF ANTIBODY CONSTRUCTS AND RELATED METHODS FOR TREATING VESTIBULAR SCHWANNOMA ASSOCIATED SYMPTOMS
#23INTRATYMPANIC DRUG CONTROLLED RELEASE-TYPE FORMULATION COMPRISING N-ACYLATED GLYCOL CHITOSAN
#24GJB2 REGULATORY ELEMENTS AND USES THEREOF
#25LENTIVIRAL GENE THERAPY RESCUES FUNCTION IN A MOUSE MODEL OF USHER 1B
#26GENE THERAPY FOR GENETIC HEARING LOSS
#27Formulation of ear drops and methods for delivery thereof for treating upper respiratory infections
#28AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE VISUAL AND AUDITORY SYSTEMS
#29SOLID DISPERSION OF RIFAXIMIN
#30METHODS AND COMPOSITIONS FOR TREATING HEARING LOSS
#31A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OTIC INFECTIONS
#32SYSTEMS AND METHODS FOR TREATMENT OF HEARING USING DIHEXA
#33CONAZOLANTIFUNGAL KETOE IN SOLUTION OR SUSPENSION FOR USE IN THE HUMAN EAR
#34ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF
#35AURIS FORMULATIONS FOR TREATING OTIC DISEASES AND CONDITIONS
#36SELF-PROPELLED PHARMACEUTICAL DELIVERY CAPSULES
#37HYPERTONIC PHARMACEUTICAL COMPOSITIONS CONTAINING AN ANTI-PLATINUM CHEMOPROTECTANT AGENT
#38Modulation of Heparin-Binding Epidermal Growth Factor Activity for Tympanic Membrane Healing
#39LENTIVIRAL VECTOR TECHNOLOGY FOR INNER EAR GENE THERAPY
#40AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE VISUAL AND AUDITORY SYSTEMS
#41OTIC FORMULATIONS, METHODS AND DEVICES
#42DRUG COMBINATION KITS AND METHODS OF DRUG DELIVERY
#43METHODS AND COMPOSITIONS FOR REDUCING NUCLEIC ACID VECTOR-INDUCED TOXICITY IN THE INNER EAR
#44METHODS OF OTOPROTECTION AGAINST PLATINUM-BASED ANTINEOPLASTIC AGENTS
#45THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE
#46COMPOUNDS FOR PROTECTION OF NOISE-INDUCED HEARING-LOSS
#47METHODS AND COMPOSITIONS FOR REDUCING NUCLEIC ACID VECTOR-INDUCED TOXICITY IN THE INNER EAR
#48METHODS OF OTOPROTECTION AGAINST PLATINUM-BASED ANTINEOPLASTIC AGENTS
#49METHOD FOR PREVENTING NASOLACRIMAL DUCT OBSTRUCTION
#50AAV-mediated delivery of therapeutic antibodies to the inner ear
#51METHOD OF IDENTIFYING A BIOLOGICALLY-ACTIVE COMPOSITION FROM A BIOFILM
#52METHOD FOR THE TREATMENT OF AN AUDITORY DISEASE OR CONDITION
#53BDNF OTIC FORMULATIONS AND USE THEREOF
#54NOVEL USE OF GLUCOCORTICOIDS FOR THE TREATMENT OF EPITHELIAL MICROBIAL INFECTIONS OF A FLUID CONTAINING ORGAN WITH A NATURAL EXTERIOR ORIFICE IN MAMMALS
#55PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INNER EAR DISORDERS THROUGH LOCAL ADMINISTRATION IN THE TYMPANIC AREA
#56PREVENTION AND/OR TREATMENT OF HEARING LOSS OR IMPAIRMENT
#57Antimicrobial compounds, compositions, and uses thereof
#584-PHENYL-TETRAHYDROPYRIDINE DERIVATIVES FOR TREATING HEARING DISEASES
#59PHARMACEUTICAL COMPOSITION FOR OTIC ADMINISTRATION
#60PROBIOTIC COMPOSITIONS AND THEIR USE TO MODULATE IMMUNE SYSTEMS
#61TREATMENT METHODS AND FORMULATIONS
#62GROWTH FACTOR OTIC FORMULATIONS
#63GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER EAR
#64PHARMACEUTICAL COMPOSITION FOR OTIC ADMINISTRATION
#65LIQUID FORMULATION COMPOSITIONS, MEDICAMENT DELIVERY DEVICES, AND METHODS OF PREPARATION AND USE THEREOF
#66Improved Supraparticles
#67GROWTH FACTOR FORMULATION FOR CONDITION ASSOCIATED WITH OTIC EVENT
#68EXCIPIENTS PROVIDING STABILIZATION AND ENHANCED WATER SOLUBILIZATION AND THEIR USES
#69SYNERGISTIC EFFECTS, AUGMENTING ANTIMICROBAL EFFECTS OF LIPIDS
#70OTOLOGICAL SURGERY UNDER PERFLUOROCARBON LIQUIDS
#71TREATMENT OF OTIC DISEASES AND CONDITIONS
#72Antimicrobial Composition
#73Antimicrobial compounds, compositions, and uses thereof
#74THERMORESPONSIVE HYDROGEL CONTAINING POLYMER MICROPARTICLES FOR CONTROLLED DRUG DELIVERY
#75Allele-specific silencing therapy for DFNA9 using antisense oligonucleotides
#76LIPID COATED IRON OXIDE NANOPARTICLES FOR OTITIS MEDIA
#77ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION COMPRISING PROBIOTICS AND ANTIBIOTICS, AND METHOD USING SAME
#78METHOD OF TREATING DISEASE
#79Hybrid System for Efficient Gene Delivery to Cells of the Inner Ear
#80LOCALIZED RELEASE OF SYSTEMICALLY CIRCULATING THERAPEUTIC SUBSTANCES
#81Method of treatment
#82COCHLEAR INNER HAIR CELL PROMOTERS AND USES THEREOF
#83COMPOSITIONS, SYSTEMS, AND METHODS FOR GENERATING INNER EAR HAIR CELLS FOR TREATMENT OF HEARING LOSS
#84ANTI-MICROBIAL SEAWEED EXTRACTS, COMPOSITIONS AND USES THEREOF
#85SODIUM THIOSULFATE GEL FOR PREVENTING OR REDUCING HEARING LOSS
#86Efficient delivery of therapeutic molecules to cells of the inner ear
#87EXTENDED-RELEASE DRUG DELIVERY COMPOSITIONS
#88AAV-mediated delivery of antibodies to the inner ear
#89COMPOSITIONS AND METHODS FOR TREATING AN INFECTION
#90INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION
#91Phosphonate-Drug Conjugates
#92Combination Therapy for Treating Disorders of the Ear
#93CIPROFLOXACIN OTIC COMPOSITION AND KITS AND METHOD FOR USING SAME
#94Fibroblast growth factor 2 (FGF2) for Treatment of Human Sensorineural Hearing Loss
#95Sensorineural Hair Cell Differentiation
#96PHARMACEUTICAL COMPOSITIONS COMPRISING OTIC THERAPEUTIC AGENTS AND RELATED METHODS
#97Methods for treating ciliated cavities
#98COMBINATION OF CHIR99021 AND VALPROIC ACID FOR TREATING HEARING LOSS
#99MICROBIAL REMOVAL
#100VALPROIC ACID COMPOUNDS AND WNT AGONISTS FOR TREATING EAR DISORDERS
#101Modulation of heparin-binding epidermal growth factor activity for tympanic membrane healing
#102Method of identifying a biologically-active composition from a biofilm
#103Trans-tympanic membrane delivery platform and uses thereof
#104ISL1-BASED GENE THERAPY TO TREAT HEARING LOSS
#105COMPOSITIONS AND METHODS FOR TREATING AN INFECTION
#106Self-Gelling Solutions for Administration of Therapeutics to the Inner Ear
#107COMPOSITIONS AND METHODS FOR THE DELIVERY OF THERAPEUTIC AGENTS ACROSS THE ROUND WINDOW MEMBRANE
#108COMPOSITIONS AND METHODS FOR TREATING NON-AGE-ASSOCIATED HEARING IMPAIRMENT IN A HUMAN SUBJECT
#109Compositions with permeation enhancers for drug delivery
#110Liquid formulation compositions, medicament delivery devices, and methods of preparation and use thereof
#111AURIS FORMULATIONS FOR TREATING OTIC DISEASES AND CONDITIONS
#112Auris formulations for treating otic diseases and conditions
#113Materials and methods for delivering nucleic acids to cochlear and vestibular cells
#114Treatment of Hearing Loss by Inhibition of Casein Kinase 1
#115Use of glucocorticoids for the treatment of epithelial microbial infections of a fluid containing organ with a natural exterior orifice in mammals
#116OTIC GEL FORMULATIONS FOR TREATING OTITIS EXTERNA
#117METHODS FOR USING ANTIMICROBIAL COMPOSITIONS
#118AAV-mediated delivery of therapeutic antibodies to the inner ear
#119AAV1 VECTORS AND USES THEREOF FOR TREATMENT OF OTIC INDICATIONS
#120ACTIVATION OF YAP SIGNALING FOR SENSORY RECEPTOR REGENERATION
#121COMPOSITIONS WITH SYNERGISTIC PERMEATION ENHANCERS FOR DRUG DELIVERY
#122METHOD TO PREVENT AND TREAT HEARING LOSS BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS
#123Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent
#1241H-PYRROLE-2,5-DIONE COMPOUNDS AND METHODS OF USING THEM TO INDUCE SELF-RENEWAL OF STEM/PROGENITOR SUPPORTING CELLS
#125Treating hearing loss
#126SOLUBILIZED COMPOSITIONS FOR CONTROLLED PROLIFERATION OF STEM CELLS / GENERATING INNER EAR HAIR CELLS USING GSK3 INHIBITORS: I
#127COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF CUTANEOUS AFFECTIONS
#128COMBINATION THERAPIES FOR INNER EAR SENSORY HAIR CELL REGENERATION/REPLACEMENT
#129Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
#130Methods of treatment using topical copper ion formulations
#131METHODS OF TREATMENT USING TOPICAL COPPER ION FORMULATIONS
#132CONTROLLED-RELEASE CNS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
#133METHODS OF TREATING COCHLEAR SYNAPTOPATHY
#134Compositions and methods for controlling cerumen production
#135Triglyceride otic formulations and uses thereof
#136TREATMENT OF TINNITUS THROUGH MODULATION OF CHLORIDE CO-TRANSPORTER NKCC1 IN THE AUDITORY SYSTEM
#137METHOD OF DELIVERING DRUGS TO INNER EAR FACILITATED BY MICROBUBBLES
#138Otic formulations, methods and devices
#139Arylamide compounds and compositions and uses thereof
#140METHODS FOR CONTROLLED PROLIFERATION OF STEM CELLS / GENERATING INNER EAR HAIR CELLS USING 2-PYRIMIDINYLAMINOETHYLAMINO-2-PYRIDYL BASED COMPOUNDS
#141AAV vectors encoding clarin-1 or GJB2 and uses thereof
#142AAV-MEDIATED DELIVERY OF THERAPEUTIC ANTIBODIES TO THE INNER EAR
#143Methods of otoprotection against platinum-based antineoplastic agents
#144TREATMENT OF DEAFNESS BY GENE THERAPY
#145Compositions and methods for treating an infection
#146Reduced Friction Eartips, And Systems And Methods Therefore
#147Thermoresponsive hydrogel containing polymer microparticles for controlled drug delivery to the ear
#148TRIGLYCERIDE OTIC FORMULATIONS AND USES THEREOF
#149Compositions and methods for treating an infection
#150SYSTEMS, APPARATUS, AND METHODS FOR DELIVERY OF THERAPEUTIC SUBSTANCE TO THE TYMPANIC MEMBRANE
#151COMPOSITIONS AND METHODS FOR TREATING NON-AGE-ASSOCIATED HEARING IMPAIRMENT IN A HUMAN SUBJECT
#152COMPOSITIONS AND METHODS FOR THE REMOVAL OF EAR WAX
#153Reduced and oxidized polysaccharides and methods of use thereof
#154Prevention and/or treatment of hearing loss or impairment
#155Trans-tympanic membrane delivery platform and uses thereof
#156Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent
#157Sensorineural hair cell differentiation
#158Auricular cleaning composition
#159Compositions, systems, and methods for generating inner ear hair cells for treatment of hearing loss
#1601,2-DIHYDRO-3H-PYRAZOL-3-ONE COMPOUNDS AND METHODS OF USING SAME
#161Fluidic dispensing apparatus and associated fluid dispensing cartridge
#162LIQUID FORMULATION COMPOSITIONS, MEDICAMENT DELIVERY DEVICES, AND METHODS OF PREPARATION AND USE THEREOF
#163ANTIMICROBIAL WASH
#164Supraparticles
#165Biophotonic compositions for the treatment of otitis externa
#166Auris formulations for treating otic diseases and conditions
#167APOPTOSIS INHIBITOR FORMULATIONS FOR PREVENTION OF HEARING LOSS
#168SELF-GELLING SOLUTIONS FOR ADMINISTRATION OF THERAPEUTICS TO THE INNER EAR
#169Methods of treatment using topical copper ion formulations
#170Pharmaceutical composition comprising Lenvatinib mesylate
#171Methods for the treatment of tinnitus induced by cochlear excitotoxicity
#172GENE THERAPY SYSTEMS AND RELATED METHODS FOR TREATMENT OF HEARING LOSS
#173Compounds that enhance Atoh1 expression
#174TOPICAL COMPOSITIONS FOR OPHTHALMIC AND OTIC USE
#175Biodegradable prosthesis
#176NEUROTROPHINS FOR USE IN THE TREATMENT OF HEARING LOSS
#177COMPOSITIONS WITH PERMEATION ENHANCERS FOR DRUG DELIVERY
#178COMPOSITIONS USING CROSS-LINKED HYALURONIC ACID FOR TOPICAL COSMETIC AND THERAPEUTIC APPLICATIONS
#179GENE THERAPY CONSTRUCTS AND METHODS FOR TREATMENT OF HEARING LOSS
#180Method of identifying a biologically-active composition from a biofilm
#181Mussel adhesive protein product and use thereof for treating mucosal inflammation
#182Topical antimicrobial compositions and methods of formulating the same
#183METHODS OF TREATING VESTIBULAR SCHWANNOMA
#184ERBB3 Activators in Hearing Restoration
#185MICRO-DISPENSER BASED EAR TREATMENT
#186Compositions and methods for generating hair cells by downregulating FOXO
#187Wax foamable vehicle and pharmaceutical compositions thereof
#188Compositions and methods for treating an infection
#189ANTIMICROBIAL COMPOSITIONS AND METHODS
#190METHOD FOR TRANSDERMAL DELIVERY OF PERMEANT SUBSTANCES
#191Method of treatment
#192PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFLAMMATORY EAR DISEASES, METHOD FOR PRODUCING SAME AND METHOD FOR TREATMENT USING SAME COMPOSITION
#193THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE
#194Combination therapy for treating disorders of the ear
#1951H-pyrrole-2,5-dione compounds and methods of using same
#196Controlled-release CNS modulating compositions and methods for the treatment of otic disorders
#197Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent
#198Arylamide compounds and compositions and uses thereof
#199Methods of treating cochlear synaptopathy
#200Auris formulations for treating OTIC diseases and conditions
#201CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
#202Oil-in-water nanoemulsion composition of clobetasol
#203FORMULATION AND COMPOSITION FOR PREVENTING AND/OR DISSOLVING BIOFILM ON THE SKIN OF A DOMESTIC ANIMAL
#204Antimicrobial compositions and methods employing same
#205METHODS FOR INDUCING STEREOCILIA ON HAIR CELLS
#206Compositions, Systems, and Methods for Generating Inner Ear Hair Cells for Treatment of Hearing Loss
#207Treatment of hearing loss by inhibition of casein kinase 1
#208Single-dose dual-compartment drug delivery system
#209Method for preventing nasolacrimal duct obstruction
#210EXTENDED-RELEASE DRUG DELIVERY COMPOSITIONS
#211METHOD OF PREVENTING OR TREATING HEARING LOSS
#212Thermostable formulation of biologically active substances
#213SYNERGISTIC EFFECTS, AUGMENTING ANTIMICROBAL EFFECTS OF LIPIDS
#214Increasing ATOH1 life to drive sensorineural hair cell differentiation
#215Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: I
#216Compositions and methods for cerumen removal
#217Dibenzo azepine compounds and their use in the treatment of otic diseases and disorders
#218CONTROLLED RELEASE DELIVERY DEVICES FOR THE TREATMENT OF OTIC DISORDERS
#219Drug-containing fat emulsion and nethod for producing same
#220METHODS OF ATTENUATING DRUG EXCIPIENT CROSS REACTIVITY
#221METHODS FOR CONTROLLED PROLIFERATION OF STEM CELLS / GENERATING INNER EAR HAIR CELLS USING GSK-3-ALPHA INHIBITORS
#222METHODS FOR CONTROLLED PROLIFERATION OF VESTIBULAR STEM CELLS / GENERATING INNER EAR HAIR CELLS USING WNT AND TGFBETA-INHIBITION
#223Compositions and methods for treating an infection
#224Agent for regenerating tympanic membrane or external auditory canal
#225Hybrid System for Efficient Gene Delivery to Cells of the Inner Ear
#226SYSTEM AND METHOD FOR DELIVERY OF A THERAPEUTIC AGENT TO THE INNER EAR
#227Phosphonate-drug conjugates
#228Biophotonic compositions for the treatment of otitis externa
#229Treatment using truncated Trk B and Trk C antagonists
#230Ciprofloxacin otic composition and kits and method for using same
#231Materials and methods for delivering nucleic acids to cochlear and vestibular cells
#232Treating hearing loss
#233Treatment of tinnitus through modulation of chloride co-transporter NKCC1 in the auditory system
#234Method of treating disease
#235Method of identifying a biologically-active composition from a biofilm
#236Reduced and oxidized polysaccharides and methods of use thereof
#237COMPOSITIONS AND METHODS COMPRISING SERRATIA PEPTIDASE FOR INHIBITION AND TREATMENT OF BIOFILMS RELATED TO CERTAIN CONDITIONS
#238LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS
#239Preparation jig for tympanic membrane regenerating agent and preparation vessel for tympanic membrane regenerating agent
#240Dibenzo azepine compounds and their use in the treatment of otic diseases and disorders
#241Systems and methods for anesthetizing ear tissue
#242Modulation of heparin-binding epidermal growth factor activity for tympanic membrane healing
#243Methods for controlled proliferation of stem cells / generating inner ear hair cells using 3-(pyridin-2-yl)-1H-indol-2-ol based compounds
#244METHODS FOR THE TREATMENT OF TINNITUS INDUCED BY COCHLEAR EXCITOTOXICITY
#245Mussel adhesive protein product and use thereof for treating mucosal inflammation
#246Mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies
#247Compositions with permeation enhancers for drug delivery
#248COMPOSITIONS COMPRISING S1P RECEPTOR MODULATORS
#249Liquid pharmaceutical composition for the delivery of active ingredients
#250Treatment of mammalian physiological reaction of IgE antibodies present in said mammal upon contact with the corresponding antigen
#251Method for preventing nasolacrimal duct obstruction
#252Treatment of otitis media with retroauricular injection of an anti-inflammatory drug
#253Controlled release antimicrobial compositions and methods for the treatment of otic disorders
#254Method and apparatus for obtaining a three-dimensional map of tympanic membrane thickness
#255COMPOSITIONS AND METHODS OF USING LAMELLAR BODIES FOR MODIFYING LINEAR BIOLOGICAL MACROMOLECULES
#256Methods of treatment using topical copper ion formulations
#257Compositions and methods for the removal of ear wax
#258MODULATION OF GEL TEMPERATURE OF POLOXAMER-CONTAINING FORMULATIONS
#259CONTROLLED RELEASE CORTICOSTEROID COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
#260Antimicrobial wash
#261OTIC GEL FORMULATIONS FOR TREATING OTITIS MEDIA
#262Otic gel formulations for treating otitis externa
#263METHODS TO PREVENT TISSUE COLONIZATION OF PATHOGENS AND FOR TREATMENT OF BIOFILM ON ANIMAL TISSUES, INCLUDING TREATMENT OF INFECTION
#264TOPICAL COPPER ION TREATMENTS AND METHODS OF TREATMENT USING SAME IN THE ORAL-RESPIRATORY-OTIC AREAS OF THE BODY
#265Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
#266Prevention and/or treatment of hearing loss or impairment
#267PREVENTION OF AND RECOVERY FROM DRUG-INDUCED OTOTOXICITY
#268PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFLAMMATORY EAR DISEASES, METHOD FOR PRODUCING SAME AND METHOD FOR TREATMENT USING SAID COMPOSITION
#269Method of Preventing or Treating Hearing Loss
#270Pharmaceutical composition for topical application in the auditory canal
#271Liquid pharmaceutical composition for the delivery of active ingredients
#272METHOD FOR TREATING OTIC INFECTIONS AFTER TYMPANOSTOMY TUBE PLACEMENT
#273Composition and method for treating congenital cytomegalovirus induced hearing loss
#274METHOD FOR PREVENTING, TREATING, AND CURING CANCER
#275Method and process for quantitative evaluation of pharmacokinetics, therapeutic effects and safety of delivery of drug compounds to the inner ear for treatment of auditory disease
#276Triglyceride otic formulations and uses thereof
#277Wax foamable vehicle and pharmaceutical compositions thereof
#278Probiotic Fermentation Products
#279Anti-microbial seaweed extracts, compositions and uses thereof
#280Non-nasal treatment methods using carbon dioxide and saline
#281Combination therapies for inner ear sensory hair cell regeneration/replacement
#282Therapeutic use of a growth factor, METRNL
#283Compositions and methods for treating an infection
#284Efficient delivery of therapeutic molecules to cells of the inner ear
#285Efficient delivery of therapeutic molecules in vitro and in vivo
#286Biodegradable prosthesis
#287INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION
#288Extended-release drug delivery compositions
#289Method of identifying a biologically-active composition from a biofilm
#290RAPAMYCIN FORMULATIONS AND METHODS OF THEIR USE
#291Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV
#292Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: III
#293Methods for controlled proliferation of stem cells / generating inner ear hair cells using 3-(pyridin-2-yl)-1H-indol-2-ol based compounds
#294Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I
#295METHODS FOR CONTROLLED PROLIFERATION OF STEM CELLS / GENERATING INNER EAR HAIR CELLS USING 2-PYRIMIDINYLAMINOETHYLAMINO-2-PYRIDYL BASED COMPOUNDS
#296SOLUBILIZED COMPOSITIONS FOR CONTROLLED PROLIFERATION OF STEM CELLS / GENERATING INNER EAR HAIR CELLS USING GSK3 INHIBITORS: II
#297ACTIVE-LOADED PARTICULATE MATERIALS FOR TOPICAL ADMINISTRATION
#298Mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies
#299METHODS FOR THE TREATMENT OF TINNITUS INDUCED BY COCHLEAR EXCITOTOXICITY
#300OTIC FORMULATIONS FOR THE TREATMENT OF CERUMINOSIS